A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Clinical trial NCT05864846 · COMPLETED
Trial details
- NCT number
- NCT05864846
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2026-04-06
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.